Dr. Timothy Wahl, MD (he/him) is an Endocrinologist in Omaha, NE with over 17 years of experience. What is your opinion of Dr. Timothy Wahl, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Timothy Wahl, MD has received over $423,072 which includes payments from the following companies:
$255,000.95 from LILLY USA, LLC
$91,417.80 from AstraZeneca Pharmaceuticals LP
$46,204.45 from sanofi-aventis U.S. LLC
$22,982.64 from Boehringer Ingelheim Pharmaceuticals, Inc.
$3,788.61 from E.R. Squibb & Sons, L.L.C.
$957.40 from Tandem Diabetes Care, Inc.
$615.45 from Janssen Pharmaceuticals, Inc
$473.91 from Novo Nordisk Inc
$198.15 from Amgen Inc.
$164.68 from Abbott Laboratories
$153.59 from Shire North American Group Inc
$103.40 from Roche Diagnostics Corporation
$93.90 from Valeritas, Inc.
$87.53 from Animas Corporation
$83.47 from INSULET CORPORATION
$73.57 from Novartis Pharmaceuticals Corporation
$64.72 from Corcept Therapeutics
$61.18 from Merck Sharp & Dohme Corporation
$60.53 from GlaxoSmithKline, LLC.
$59.24 from Takeda Pharmaceuticals America, Inc.
Payments received by Dr. Timothy Wahl, MD were from the following categories:
$366,098.24 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!